Watch: Menten AI’s Generative Approach to Peptide Design

Associate Director, Stephan Kudlacek, Discussed MAUD 1.0 at Drug Discovery Chemistry

This past April, Stephan Kudlacek showcased the power of our MAUD 1.0 platform at the Drug Discovery Chemistry conference. From initial target modeling to successful experimental validation, Stephan detailed our end-to-end generative AI approach and shared the latest validation data. Watch the full presentation below to see how we are redefining peptide design and drug discovery.

Learn more about Menten AI's platform MAUD 1.0 on our website.

‍